K74.02 Hepatic fibrosis, advanced fibrosis

Name of the Condition

• Hepatic Fibrosis, Advanced Fibrosis (ICD-10-CM Code: K74.02)

Summary

Hepatic fibrosis, advanced fibrosis, is a condition characterized by significant scarring of the liver tissue, indicating substantial liver damage. This advanced stage of fibrosis represents a progression beyond early or mild fibrosis and may precede or coexist with cirrhosis. The scarring impairs liver function and can lead to complications if not addressed.

Causes

Advanced hepatic fibrosis typically results from prolonged or severe chronic liver injury. Common causes include chronic viral hepatitis (e.g., hepatitis B or C), long-term alcohol use, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver conditions. Prolonged exposure to toxins, certain medications, or genetic liver disorders may also contribute to advanced fibrosis.

Risk Factors

• Chronic viral hepatitis infections (B or C)
• Excessive alcohol consumption
• Obesity and metabolic syndrome
• Type 2 diabetes
• High cholesterol or triglycerides
• Genetic predispositions to liver disease
• Prolonged exposure to liver toxins or medications

Symptoms

Symptoms may be mild or absent in early stages but often become more apparent as fibrosis advances. Common signs include:

• Fatigue
• Jaundice (yellowing of skin or eyes)
• Abdominal discomfort or swelling
• Easy bruising or bleeding
• Swelling in legs or abdomen (edema/ascites)
• Unexplained weight loss

Diagnosis

Diagnosis involves a combination of clinical evaluation and testing. Blood tests assess liver function and markers of fibrosis. Imaging studies (e.g., ultrasound, CT, or MRI) evaluate liver structure. Liver biopsy or elastography may be used to confirm the extent of fibrosis and rule out cirrhosis.

Treatment Options

Treatment focuses on addressing the underlying cause and managing complications. This may include antiviral therapy for hepatitis, alcohol cessation, weight management for NAFLD, or immunosuppressants for autoimmune conditions. Medications to reduce liver inflammation or slow fibrosis progression may be prescribed. In advanced cases, liver transplantation could be considered.

Prognosis and Follow-Up

Prognosis depends on the underlying cause, extent of fibrosis, and response to treatment. Early intervention can slow or stabilize fibrosis, but advanced stages may lead to irreversible damage. Regular follow-up with liver function tests, imaging, or biopsies is essential to monitor disease progression and adjust treatment.

Complications

Advanced fibrosis increases the risk of complications, including:

• Cirrhosis (severe scarring)
• Liver failure
• Portal hypertension (increased blood pressure in liver vessels)
• Esophageal varices (enlarged veins in the esophagus)
• Hepatocellular carcinoma (liver cancer)

Lifestyle & Prevention

• Limit alcohol consumption or avoid it entirely
• Maintain a healthy weight and manage metabolic conditions
• Vaccinate against hepatitis A and B
• Avoid exposure to liver toxins or unnecessary medications
• Follow a balanced diet and exercise regularly
• Monitor and manage chronic conditions like diabetes or high cholesterol

When to Seek Professional Help

Seek medical attention if you experience persistent fatigue, jaundice, unexplained weight loss, abdominal swelling, or signs of bleeding (e.g., easy bruising). Early evaluation is critical for managing advanced fibrosis and preventing complications.

Tips for Medical Coders

When coding K74.02, ensure documentation supports the diagnosis of advanced fibrosis. Clinical notes should specify the extent of fibrosis (e.g., via biopsy or imaging) and exclude cirrhosis if present. Verify that the underlying cause (e.g., hepatitis, alcohol use) is documented to support accurate coding. Use this code only when advanced fibrosis is confirmed, not for milder stages or unspecified fibrosis.